The company expects product sales of approx. $2 billion in the first half of 2023.
Moderna (MRNA) Earnings: 4Q22 Key Numbers
Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due to a drop in COVID-19 vaccine sales. Net income decreased by 70% to $1.5 billion while EPS dropped by 68% to $3.61 compared to the same period last year. The company expects product sales of […]
NYSE
$MRNA · Earnings
“Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due to a drop in COVID-19 vaccine sales. Net income decreased by 70% to $1.5 billion while EPS dropped by 68% to $3.61 compared to the same period last year. The company expects product sales of […]
· February 23, 2023
Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due to a drop in COVID-19 vaccine sales.
Net income decreased by 70% to $1.5 billion while EPS dropped by 68% to $3.61 compared to the same period last year.
ADVERTISEMENT